CardioLogs (acquired by Philips in 2021)
About CardioLogs (acquired by Philips in 2021)
CardioLogs, acquired by Philips in 2021, is a healthcare AI company specializing in transforming cardiac diagnostics through artificial intelligence and cloud technology. Their core offering is a vendor-neutral, cloud-based ECG analysis platform that utilizes deep neural networks to provide fast and accurate cardiac diagnostics. This platform is designed to streamline ECG analysis, reduce reporting errors, and improve clinician workflow and patient care, making expert cardiac care more accessible and efficient.
For physicians, CardioLogs’ technology offers significant advantages in the detection of various cardiac arrhythmias, including Atrial Fibrillation or Atrial Flutter, Ventricular Tachycardia, and different types of premature complexes and blocks. The AI model is built on an extensive database of over 20 million ECG recordings and is CE marked and FDA cleared for detecting cardiac arrhythmias. It can interpret data from a range of cardiac monitoring devices, such as smartwatches, Holter monitors, or ECG patches, and generate rapid reports, thereby reducing the burden of manual ECG interpretation and enhancing diagnostic scalability. The integration of CardioLogs’ AI into Philips’ cardiac care portfolio aims to further strengthen Philips’ offerings in real-time patient monitoring, therapeutic devices, telehealth, and informatics for both hospital and ambulatory settings.
Focus Areas
Business Intelligence
| Technology | Cloud-based AI platform utilizing deep neural network (DNN) technology for ECG analysis |
What Physicians Need to Know
CardioLogs' AI-powered platform significantly accelerates diagnostic reporting and reduces reporting errors, streamlining clinician workflow and patient care. Physicians can expect a reduction in Holter analysis time by approximately 42%, allowing them to focus on meaningful episodes. The platform's ability to analyze longer recordings with minimal additional analysis time (less than 1 minute per day of additional recording) is particularly beneficial. The vendor-neutral approach means compatibility with various recording devices, simplifying integration into existing practices. Furthermore, the remote patient monitoring capabilities, including smartwatch integration, offer new avenues for proactive patient management and early detection of conditions like AFib. The platform is designed to prioritize data needing the most attention and provides an efficient workflow for reviewing ECG strips.
CardioLogs' Holter platform is compatible with ECGs recorded in devices from multiple vendors and can be electronically interfaced with data transferred from other computer-based ECG systems, such as an ECG management system. The company also offers an Application Programming Interface (API) for integration. While CardioLogs was acquired by Philips, its platform is designed to be vendor-neutral, allowing for flexibility in device usage.
What the Web Says
CardioLogs, acquired by Philips in 2021, is a medical technology company specializing in AI and cloud-based cardiac diagnostics, particularly for ECG analysis and arrhythmia detection. Their technology is designed to streamline clinician workflow, accelerate diagnostic reporting, and reduce errors. The company's Holter Platform is noted as the first FDA-cleared ECG analysis solution powered by deep learning technology.
Overall: PositiveStrengths
- Clinically validated AI algorithms for arrhythmia detection.
- Reduces reporting errors and streamlines clinician workflow.
- Vendor-neutral platform, compatible with various cardiac monitoring devices.
- Accelerates diagnostic reporting.
- First FDA-cleared ECG analysis solution powered by deep learning technology.
- Strong focus on making cardiology diagnostics scalable and accessible.
Limitations
- Limited public reviews available specifically for CardioLogs as a standalone company post-acquisition by Philips.
- No specific employer reviews for CardioLogs found on Glassdoor or Reddit.
- Pricing information for CardioLogs products is not readily available publicly.
- Some advanced features, like smartwatch data analysis and ECG biomarkers, are still under investigation and not yet available for sale.
Based on reviews from: SourceForge, The Signify View, MedTech Dive, Respiratory Therapy, Philips, Software Suggest, IoT M2M Council, DAIC, Cardiovascular Business, Reddit
Last updated: 2026-10-18
Videos
News, demos, and interviews about CardioLogs (acquired by Philips in 2021).
Videos load interactively. If none appear, search YouTube for CardioLogs (acquired by Philips in 2021) →
Press & Coverage
Frequently Asked Questions
Comparisons
When choosing between CardioLogs ECG Analysis Platform and PMcardio, physicians should consider their primary use case and desired deployment. CardioLogs, now a Philips solution, excels in comprehensive, high-volume ECG data analysis from various cardiac monitoring devices, making it ideal for practices managing extensive Holter, smartwatch, or ECG patch data. Its cloud-based SaaS deployment and pay-per-ECG […]
Related Companies
Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]
Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]
Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]
Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]
HeartLung.AI is a health-tech company focused on leveraging artificial intelligence for the early detection and prevention of cardiovascular disease and lung cancer. Their mission is to shift healthcare from late-stage disease treatment to earlier identification and prevention by unlocking clinically actionable information embedded within routine medical imaging. The company has developed several FDA-cleared and breakthrough-designated […]
Heartvue.ai is a healthcare AI company focused on transforming cardiovascular imaging analysis. Founded by a cardiologist with over two decades of experience in advanced cardiac imaging, the company develops AI-powered tools to make advanced cardiac imaging analysis more accessible, consistent, and efficient for healthcare systems. Their mission is to alleviate the burden of manual workflows […]